<
>

At CHDR we focus on data-intensive, early phase clinical studies in healthy volunteers and patients, where pharmacokinetic and pharmacodynamic parameters are obtained and combined.

CHDR has a wide-ranging self-funded research program where biomarkers are explored for pharmacological responses or other indicators related to a therapeutic intervention.

CHDR employs medical experts who leverage their pharmacological know-how to efficiently guide the drug development process.

MEET OUR PEOPLE:

Adam Cohen

CEO
Read more

Koos Burggraaf

Research Director CVS & Metabolism
Read more

Joop van Gerven

Research Director CNS
Read more

Geert Jan Groeneveld

Research Director Neurology & Pain
Read more

Pierre Peeters

Research Director & COO
Read more

Ria Kroon

Director Clinical Operations
Read more

Margreet Rienstra

Quality Assurance Manager
Read more

Ingrid de Visser

Senior Clinical Scientist
Read more

Wolf Ondracek

Managing Director OmniComm Promasys BV
Read more

Justin Hay

Senior Clinical Scientist
Read more

Matthijs Moerland

Senior Clinical Scientist
Read more

Robert Rissmann

Director of Education
Read more

Bart Mooy

Financial Director
Read more

Rob Zuiker

Senior Clinical Scientist
Read more